Levitee Labs Inc. announced that the Company has entered into a strategic partnership via a services agreement with Canntab Therapeutics Limited. Pursuant to the Agreement, Levitee will, where applicable, inform customers throughout its ecosystem of specialized clinics and pharmacies in Alberta and British Columbia about Canntab products as alternative solutions for pain management, addiction, and other disorders. Levitee currently owns five addiction clinics and three specialized pharmacies which have conducted more than 35,000 patient visits in the last 12 months.

The partnership is anticipated to enhance patient care and drive additional revenue.